pharmaceutical drugs

SPOTLESS · Screening of small molecules to fight SARS-CoV-2 by combining novel approaches and sustainability

cubiform · Development of mucosal vaccines based in crosslinked-mucin glycoproteins and chitosan-based nanodevices

VacCan · Development of new multi-valent vaccine systems against Candida pathogens

DIMEvAR · Impact of medical drugs on the evolution of human microbiome function and antimicrobial resistance development

GRASSHOPPER · understandinG the Role of codon usAge biaS in viruS HOst jumP ProcessEs thRough statistical physics

ScrIntOR · Genome-wide CRISPR/Cas9 screen in intestinal organoids for identification and molecular characterization of therapeutic targets to enhance tissue regeneration

REMIND EBOV · Role of the mucin-like domain of the Ebola virus in modulating virus-glycosaminoglycan interactions

Slow growth · Deciphering the molecular mechanism(s) behind the evolution of Mycobacterium tuberculosis towards slow growth, and the impact on virulence and persistence

AGAPE · Accessory Genome Accountability in Pseudomonas aeruginosa Persistent Infections

ASSERT · Development of a nanotechnology-based innovative assay for the diagnosis of allergy to Betalactams

ECO-SOS · Development of Emerging Contaminants – Hybrid Soft Sensor for on-line monitoring of contaminants of emerging concern in water

plasTCD · Targeting dendritic cell plasticity to modulate antigen-specific T cell recall responses in human

HYPOVACC · Hydrogel/Polymersome-based Subunit Vaccines in the Fight Against COVID-19

2 partners · 2 countries

Pain_App · Predicting neuropathic pain episodes in spinal cord injury patients through portable EEG and machine learning

PANC561 · LAM561 BEATS PANCREATIC CANCER

ASPIRATION · Soft Template Mediated Peptide Crystallisation

PHOTO-ITU · Merging enantioselective isothiourea catalysis with visible-light photoactivation for the synthesis of biologically-relevant chiral molecules

SHIFT · Dissecting the role of sex hormones in human antiviral immunity

MART · Mucosal antibody and B cell responses during Tuberculosis

MYCOBIOMICS · Joining forces to exploit the mycobiota of Asia, Africa and Europe for beneficial metabolites and potential biocontrol agents, using -OMICS techniques

8 partners · 7 countries

SusWater · Sustainable integrated approach to achieve CECs and PTEs removal from contaminated waters. The aquaculture as case study

9 partners · 6 countries

SAFEMILK · Innovative technology for milk safety

12 partners · 6 countries

PEST-BIN · Pioneering Strategies Against Bacterial Infections

11 partners · 7 countries

CC-TOP · C-C Bond Formation Using Top Performing Enzymes

12 partners · 6 countries